Rosenwald Lindsay A MD's Form 4 filing
Fortress Biotech, Inc. (FBIO) · filed May 20, 2024
- Accession no.
- 0001104659-24-063455
- Filed
- May 20, 2024
- Trade date
- May 16, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $17.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosenwald Lindsay A MDCIK 0000941841 | Director, Officer (President, CEO & Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | COMMON STOCK, PAR VALUE $0.001 | PPurchaseAcquired | +10,000 | $1.76 | +$17,600 | 2,873,905 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.